NEJM Interview: Jerry Avorn on the role of litigation in addressing product-related damage to hea... @NEJMgroup
NEJM Interview: Jerry Avorn on the role of litigation in addressing product-related damage to hea...  @NEJMgroup
Uploaded July 2026 | Updated September 2026, 1 week ago
Jerry Avorn is a professor of medicine at Harvard Medical School and the codirector of the Program on Regulation, Therapeutics, and Law at Harvard Medical School and Brigham and Women’s Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J. Avorn. Products That Pose Health Risks — Can Litigation Protect Us When Government Fails? N Engl J Med 2026;395:421-423.
NEJM Interview: Jerry Avorn on the role of litigation in addressing product-related damage to hea...Endovascular Treatment of Medium-Vessel-Occlusion Strokes (ORIENTAL-MeVO)Clinical Practice: Otitis Media in Young ChildrenMeet the EquationDr. Glaucomflecken Explains: Tecovirimat for the Treatment of Mpox (STOMP/A5418)Dr. Glaucomflecken Explains: Enfortumab Vedotin and Pembrolizumab in Bladder Cancer (KEYNOTE-905)OpenAI’s Karan Singal on HealthBench and the Future of Medical AIIntention to Treat: The Race Equation (Teaser)Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk (SINGLE-AF)NEJM Outbreaks Updates — Andes HantavirusNEJM This Week — August 13, 2026Dr. Glaucomflecken Explains: Transdermal Estradiol in Prostate Cancer
NEJM Group |

NEJM Interview: Jerry Avorn on the role of litigation in addressing product-related damage to hea...

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER